STUDY OF THE HYPOGLYCEMIC AND CARDIOPROTECTIVE EFFECT OF EMPAGLIFLOZIN IN THERAPY OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. World Bulletin of Public Health, [S. l.], v. 18, p. 9–14, 2023. Disponível em: https://scholarexpress.net/index.php/wbph/article/view/1965. Acesso em: 2 apr. 2026.